Ravi Mehrotra

Stock Analyst at UBS

(0.03)

# 3,986

Out of 4,667 analysts

3

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Industrials Healthcare

Top Industries:

Specialty Industrial Machinery Biotechnology

Stocks Rated by Ravi Mehrotra

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IR Ingersoll Rand	Assumes: Buy	$102 → $124	$103.11	+20.26%	1	Nov 13, 2024
	CRSP CRISPR Therapeutics AG	Downgrades: In-Line	$85 → $52	$47.26	+10.03%	2	Feb 3, 2020

Ingersoll Rand

Nov 13, 2024

Assumes: Buy

Price Target: $102 → $124

Current: $103.11

Upside: +20.26%

CRISPR Therapeutics AG

Feb 3, 2020

Downgrades: In-Line

Price Target: $85 → $52

Current: $47.26

Upside: +10.03%